Literature DB >> 1349352

Direct photoaffinity labeling of tubulin with taxol.

S Rao1, S B Horwitz, I Ringel.   

Abstract

BACKGROUND: Taxol is a potent inhibitor of the replication of eukaryotic cells and has significant antitumor activity in human malignancies. The drug induces the formation of bundles of stable microtubules and blocks cells in the mitotic phase of the cell cycle. In vitro, taxol enhances the polymerization of tubulin to microtubules that are resistant to depolymerization. Although it is evident that taxol interacts with the tubulin-microtubule system, no information has been available on the binding site for the drug on the microtubule.
PURPOSE: Our purpose was to determine if taxol binds to one or both of the tubulin subunits.
METHODS: In the absence of a photoaffinity-labeled analogue of taxol, [3H]taxol was used directly to photolabel tubulin. A complex of microtubule protein and [3H]taxol was irradiated by ultraviolet light and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. RESULTS AND
CONCLUSIONS: The radiolabeled drug preferentially binds covalently to the beta-subunit of tubulin, and the binding can be competed with unlabeled taxol. IMPLICATIONS: This observation is the first step in a study to determine the binding site for taxol on the microtubule.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1349352     DOI: 10.1093/jnci/84.10.785

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  27 in total

1.  The binding conformation of Taxol in beta-tubulin: a model based on electron crystallographic density.

Authors:  J P Snyder; J H Nettles; B Cornett; K H Downing; E Nogales
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

Review 2.  Mechanisms of Taxol resistance related to microtubules.

Authors:  George A Orr; Pascal Verdier-Pinard; Hayley McDaid; Susan Band Horwitz
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

3.  Paclitaxel and docetaxel. Innovation, but at what cost?

Authors:  P E Lønning
Journal:  Pharmacoeconomics       Date:  1995-07       Impact factor: 4.981

4.  Heat shock protein 90 mediates macrophage activation by Taxol and bacterial lipopolysaccharide.

Authors:  C A Byrd; W Bornmann; H Erdjument-Bromage; P Tempst; N Pavletich; N Rosen; C F Nathan; A Ding
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 5.  Microtubule targeting agents: from biophysics to proteomics.

Authors:  D Calligaris; P Verdier-Pinard; F Devred; C Villard; D Braguer; Daniel Lafitte
Journal:  Cell Mol Life Sci       Date:  2010-01-28       Impact factor: 9.261

Review 6.  New microtubular agents in pediatric oncology.

Authors:  N L Seibel; G H Reaman
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

7.  Relating molecular flexibility to function: a case study of tubulin.

Authors:  Ozlem Keskin; Stewart R Durell; Ivet Bahar; Robert L Jernigan; David G Covell
Journal:  Biophys J       Date:  2002-08       Impact factor: 4.033

8.  Synthesis and Biological Evaluation of a Biotinylated Paclitaxel With an Extra-Long Chain Spacer Arm.

Authors:  Lev G Lis; Mary A Smart; Anna Luchniak; Mohan L Gupta; Vadim J Gurvich
Journal:  ACS Med Chem Lett       Date:  2012-07-30       Impact factor: 4.345

9.  Distinct pose of discodermolide in taxol binding pocket drives a complementary mode of microtubule stabilization.

Authors:  Marina Khrapunovich-Baine; Vilas Menon; Pascal Verdier-Pinard; Amos B Smith; Ruth Hogue Angeletti; Andras Fiser; Susan Band Horwitz; Hui Xiao
Journal:  Biochemistry       Date:  2009-12-15       Impact factor: 3.162

10.  Steady-state plasma concentrations and effects of taxol for a 250 mg/m2 dose in combination with granulocyte-colony stimulating factor in patients with ovarian cancer.

Authors:  C A Jamis-Dow; R W Klecker; G Sarosy; E Reed; J M Collins
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.